OVERVIEW

26th Annual San Diego Heart Failure Winter Symposium: New Strategies for Detection, Prevention and Treatment of Heart Failure is organized by Complete Conference Management (CCM) and will be held from Jan 23 - 24, 2026 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.

Description:
This year's 26th Annual San Diego Heart Failure Winter Symposium - New Strategies for Detection, Prevention and Treatment of Heart Failure aims to provide a comprehensive overview of how to best manage patients with heart failure at all stages of disease. This accredited program emphasizes practical aspects of heart failure management beginning with prevention of clinically manifest disease in patients at risk and extending to end-stage heart failure. Over the course of two days, the focused sessions that include lectures, case discussions and moderated panels will provide expert insight and personal experience that cover the full range of management options that are available for managing patients throughout the spectrum of heart failure. The agenda of the Winter 2026 Symposium includes content that extends from recognition of patients with cardiovascular-renal-metabolic syndrome (CRMS) who are risk of developing heart failure to the management of patients with symptomatic heart failure including those with cardiogenic shock or end-stage disease. Advances in drug and device therapy will receive extensive coverage throughout the Symposium. Insights into the recognition and management of less common (but not less important) causes of disease including genetic mutations are important areas that will be reviewed.

Throughout the Symposium, best practices and emerging strategies for diagnosis and treatment are emphasized. By combining case vignettes, patient narratives, didactic lectures and insightful panel discussions, attendees will have the opportunity to gain state of the art insights into the management of patients with heart failure.

Symposium Objectives:

Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure